Collaboration Breeds Success

For future assay panels, novel applications, and exclusive products

Explore exciting opportunities we've identified.

Precision Oncology for Earlier Detection

The detection of circulating tumor DNA (ctDNA) in blood brings several advantages to traditional methods of biopsy. Cancer testing using blood samples allow for more frequent, earlier detection.

Liquid Biopsy for Companion Diagnostics

New Paradigm in Diagnostics

In June 2016, the US FDA approved the cobas® EGFR Mutations Test v2 as the first ever liquid biopsy companion diagnostics test, paving the way for liquid biopsy applications worldwide.

Targeted Genetic Analysis Enables Dynamic Data

Earlier Adjustment Saves Lives

Infectious Disease Study & Control

Digital PCR technology makes the detection of rare mutations possible right at the local lab or hospital. With a fast turnaround time and process automation, QLoci gives clinical labs the ability to react quickly and efficiently.

Make An Inquiry About QLoci™